Incidencia, prevalencia y mortalidad del cáncer ovárico en Aragón: estimativas y proyecciones para el período de 1998 a 2022.
Saved in:
| Title: | Incidencia, prevalencia y mortalidad del cáncer ovárico en Aragón: estimativas y proyecciones para el período de 1998 a 2022. |
|---|---|
| Alternate Title: | Incidence, Prevalence and Mortality of Kidney Cancer in Spain: Estimates and Projections for the 1998 to 2022 Period. |
| Authors: | Del Ser, Mercedes Calleja1, Corella Aznar, Elena Guadalupe1, Pérez, Milagros Bernal1 Mibernal@unizar.es |
| Source: | Medicina Naturista. jul-dic2012, Vol. 6 Issue 2, p109-116. 8p. |
| Subjects: | OVARIAN cancer prevention, OVARIAN cancer treatment, RENAL cancer, CANCER-related mortality, DISEASE incidence, DISEASE prevalence |
| Geographic Terms: | SPAIN |
| Abstract (English): | Objective: To estimate ovarian cancer incidence and prevalence in Aragon, based on mortality and survival data from the period 1998-2008, and to provide projections of incidence, prevalence and mortality until the year 2022. Material and methodology: All-cause and ovarian-cancer mortality rates were obtained from the National Statistics Institute and survival data were obtained from the EUROCARE study. Estimations were carded out using the MIAMOD program. The Joinpoint program was used to quantify the expected annual change in the projections. Results: An decrease in the incidence rate is expected in women from, this going from 18.6 (Adjusted Rate - AR = 9.2) per 100,000 inhabitants/year to 14.26 (AR = 6.83). Prevalence would decrease from 205.99 (AR = 51.62) to 168.03 (AR = 59.57), and mortality would decrease from 9.2 (AR = 6.02) to 6.83 (AR = 3.98) cases per 100.000 inhabitants/year. Conclusion: The projections indicate that ovarian cancer in Aragon follows an decreasing trend in incidence, mortality and prevalence. This needs to be considered in order to analyze the causes related to plan prevention and treatment that could have a positive effect on it. [ABSTRACT FROM AUTHOR] |
| Abstract (Spanish): | Objetivos: Estimar la incidencia y la prevalencia del cáncer de ovario en Aragón basándose en datos de mortalidad y supervivencia del período de 1998 a 2008 y proporcionar proyecciones de incidencia, prevalencia y mortalidad hasta el año 2022. Material y metodología: La mortalidad por todas las causas y para el cáncer de ovario se obtuvo del Instituto Nacional de Estadística y los datos de supervivencia del estudio EUROCARE. Las estimaciones han sido realizadas utilizando el programa MIAMOD. El programa Joinpoint ha sido utilizado para cuantificar el cambio anual que se espera en las proyecciones. Resultados: En mujeres se espera un descenso de la tasa de incidencia de 18,6 (tasa ajustada [TA] = 9,2) casos por 100.000 habitantes/año a 14,26 (TA = 6,83). La prevalencia disminuiría de 205,99 casos por 100.000 habitantes (TA = 51,62) a 168,03 (TA = 59,57) y la mortalidad de 9,2 (TA = 6,02) a 6,83 (TA = 3,98). Conclusiones: Las proyecciones indican que el cáncer ovárlco en Aragón sigue una tendencia de descenso en la incidencia, mortalidad y prevalencia, que necesitan ser consideradas para analizar las posibles causas en cuanto a medidas de prevención y tratamiento que pueden haber tenido un efecto positivo en ello. [ABSTRACT FROM AUTHOR] |
| Copyright of Medicina Naturista is the property of Sociedad Europea de Medicina Naturista Clasica (Seccion Espanola) and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | MedicLatina |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: lth DbLabel: MedicLatina An: 79625426 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Incidencia, prevalencia y mortalidad del cáncer ovárico en Aragón: estimativas y proyecciones para el período de 1998 a 2022. – Name: TitleAlt Label: Alternate Title Group: TiAlt Data: Incidence, Prevalence and Mortality of Kidney Cancer in Spain: Estimates and Projections for the 1998 to 2022 Period. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Del+Ser%2C+Mercedes+Calleja%22">Del Ser, Mercedes Calleja</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Corella+Aznar%2C+Elena+Guadalupe%22">Corella Aznar, Elena Guadalupe</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Pérez%2C+Milagros+Bernal%22">Pérez, Milagros Bernal</searchLink><relatesTo>1</relatesTo><i> Mibernal@unizar.es</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Medicina+Naturista%22">Medicina Naturista</searchLink>. jul-dic2012, Vol. 6 Issue 2, p109-116. 8p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22OVARIAN+cancer+prevention%22">OVARIAN cancer prevention</searchLink><br /><searchLink fieldCode="DE" term="%22OVARIAN+cancer+treatment%22">OVARIAN cancer treatment</searchLink><br /><searchLink fieldCode="DE" term="%22RENAL+cancer%22">RENAL cancer</searchLink><br /><searchLink fieldCode="DE" term="%22CANCER-related+mortality%22">CANCER-related mortality</searchLink><br /><searchLink fieldCode="DE" term="%22DISEASE+incidence%22">DISEASE incidence</searchLink><br /><searchLink fieldCode="DE" term="%22DISEASE+prevalence%22">DISEASE prevalence</searchLink> – Name: SubjectGeographic Label: Geographic Terms Group: Su Data: <searchLink fieldCode="DE" term="%22SPAIN%22">SPAIN</searchLink> – Name: Abstract Label: Abstract (English) Group: Ab Data: Objective: To estimate ovarian cancer incidence and prevalence in Aragon, based on mortality and survival data from the period 1998-2008, and to provide projections of incidence, prevalence and mortality until the year 2022. Material and methodology: All-cause and ovarian-cancer mortality rates were obtained from the National Statistics Institute and survival data were obtained from the EUROCARE study. Estimations were carded out using the MIAMOD program. The Joinpoint program was used to quantify the expected annual change in the projections. Results: An decrease in the incidence rate is expected in women from, this going from 18.6 (Adjusted Rate - AR = 9.2) per 100,000 inhabitants/year to 14.26 (AR = 6.83). Prevalence would decrease from 205.99 (AR = 51.62) to 168.03 (AR = 59.57), and mortality would decrease from 9.2 (AR = 6.02) to 6.83 (AR = 3.98) cases per 100.000 inhabitants/year. Conclusion: The projections indicate that ovarian cancer in Aragon follows an decreasing trend in incidence, mortality and prevalence. This needs to be considered in order to analyze the causes related to plan prevention and treatment that could have a positive effect on it. [ABSTRACT FROM AUTHOR] – Name: Abstract Label: Abstract (Spanish) Group: Ab Data: Objetivos: Estimar la incidencia y la prevalencia del cáncer de ovario en Aragón basándose en datos de mortalidad y supervivencia del período de 1998 a 2008 y proporcionar proyecciones de incidencia, prevalencia y mortalidad hasta el año 2022. Material y metodología: La mortalidad por todas las causas y para el cáncer de ovario se obtuvo del Instituto Nacional de Estadística y los datos de supervivencia del estudio EUROCARE. Las estimaciones han sido realizadas utilizando el programa MIAMOD. El programa Joinpoint ha sido utilizado para cuantificar el cambio anual que se espera en las proyecciones. Resultados: En mujeres se espera un descenso de la tasa de incidencia de 18,6 (tasa ajustada [TA] = 9,2) casos por 100.000 habitantes/año a 14,26 (TA = 6,83). La prevalencia disminuiría de 205,99 casos por 100.000 habitantes (TA = 51,62) a 168,03 (TA = 59,57) y la mortalidad de 9,2 (TA = 6,02) a 6,83 (TA = 3,98). Conclusiones: Las proyecciones indican que el cáncer ovárlco en Aragón sigue una tendencia de descenso en la incidencia, mortalidad y prevalencia, que necesitan ser consideradas para analizar las posibles causas en cuanto a medidas de prevención y tratamiento que pueden haber tenido un efecto positivo en ello. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Medicina Naturista is the property of Sociedad Europea de Medicina Naturista Clasica (Seccion Espanola) and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=lth&AN=79625426 |
| RecordInfo | BibRecord: BibEntity: Languages: – Code: spa Text: Spanish PhysicalDescription: Pagination: PageCount: 8 StartPage: 109 Subjects: – SubjectFull: OVARIAN cancer prevention Type: general – SubjectFull: OVARIAN cancer treatment Type: general – SubjectFull: RENAL cancer Type: general – SubjectFull: CANCER-related mortality Type: general – SubjectFull: DISEASE incidence Type: general – SubjectFull: DISEASE prevalence Type: general – SubjectFull: SPAIN Type: general Titles: – TitleFull: Incidencia, prevalencia y mortalidad del cáncer ovárico en Aragón: estimativas y proyecciones para el período de 1998 a 2022. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Del Ser, Mercedes Calleja – PersonEntity: Name: NameFull: Corella Aznar, Elena Guadalupe – PersonEntity: Name: NameFull: Pérez, Milagros Bernal IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: jul-dic2012 Type: published Y: 2012 Identifiers: – Type: issn-print Value: 15763080 Numbering: – Type: volume Value: 6 – Type: issue Value: 2 Titles: – TitleFull: Medicina Naturista Type: main |
| ResultId | 1 |
